Added to YB: 2025-05-21
Pitch date: 2025-05-19
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+71.62%
current return
Author Info
Duck Pond Value Research is seeking tranquil ponds with a value philosophy. Margin of safety is not just a mantra. Follow us for investment theses, sector reports, or our economic perspectives. Sometimes ponds can be moats. Sign up for the newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 36.9B
Pitch Price
EUR 23.13
Price Target
60.00 (+51%)
Dividend
0.29%
EV/EBITDA
7.31
P/E
-10.20
EV/Sales
1.47
Sector
Pharmaceuticals
Category
turnaround
Bayer Aktiengesellschaft - $BAYN.DE
BAYN.DE (update): 2025 'most difficult turnaround year' per CEO, facing ag sector headwinds, Xarelto patent loss, legal issues. Progress: workforce -9%, org restructuring from 12 to 6 layers (target 3). RoundUp: 60% win rate; new strategy aligns with farmers vs courts. Q1 pharma beat expectations, ag flat at midpoint. Valuation €60, 40% upside from current levels.
Read full article (6 min)